Announcement by Zhejiang Huahai Pharmaceutical Co., Ltd. on the Maturity of Cash Management Using Part of Idle Raised Funds

MaticHoleFiller · 2026-03-21T09:08:54+00:00

Huahai Pharmaceuticals announced the use of idle raised funds for cash management, with a maximum amount not exceeding 430 million yuan, for a period of up to 12 months. The cash management products already purchased are demand deposit agreements, with compliant fund management and matured products. There are no overdue or non-compliant usage situations.

MaticHoleFiller

2026-03-21 09:08:54

Abstract generation in progress

Stock Code: 600521 Stock Abbreviation: Huahai Pharmaceutical Announcement No.: 临2026-016

Bond Code: 110076 Bond Abbreviation: Huahai Convertible Bond

Zhejiang Huahai Pharmaceutical Co., Ltd.

Announcement on the Maturity of Using Part of Idle Raised Funds for Cash Management

Our board of directors and all directors guarantee that the content of this announcement is free from any false records, misleading statements, or major omissions, and bear individual and joint responsibility for its truthfulness, accuracy, and completeness.

Basic Situation of Using Idle Raised Funds for Cash Management

On March 20, 2025, the company held the 34th extraordinary meeting of the eighth board of directors, which approved the proposal on using part of idle raised funds for cash management. The company and its subsidiaries are allowed to use no more than 430 million yuan of idle raised funds for cash management. The usage period shall not exceed 12 months from the date of approval by the board of directors. Within the specified amount and period, the funds can be used cyclically.

For details, please refer to the announcement titled “Zhejiang Huahai Pharmaceutical Co., Ltd. on Using Part of Idle Raised Funds for Cash Management,” published on March 21, 2025, in China Securities Journal, Shanghai Securities Journal, Securities Times, Securities Daily, and on the Shanghai Stock Exchange website (www.sse.com.cn).

Overall Situation of Cash Management with Idle Raised Funds

The company and subsidiaries used part of the idle raised funds to purchase cash management products, all of which are agreed deposits. These products are of a current account nature, available for withdrawal at any time. The relevant funds are all implemented within the dedicated account for raised funds, with no fund transfers or redemptions, nor overdue collection issues.

As of the date of this announcement, the cash management using part of the idle raised funds has matured. The maximum single-day balance and usage period are within the scope of the board’s authorization, with no other violations or improper uses.

This announcement is hereby made.

Zhejiang Huahai Pharmaceutical Co., Ltd.

Board of Directors

March 19, 2026

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.

1 Likes